United States v. Shoulders

CourtCourt of Appeals for the Fifth Circuit
DecidedDecember 11, 2025
Docket24-10600
StatusUnpublished

This text of United States v. Shoulders (United States v. Shoulders) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Shoulders, (5th Cir. 2025).

Opinion

Case: 24-10600 Document: 91-1 Page: 1 Date Filed: 12/11/2025

United States Court of Appeals for the Fifth Circuit ____________ United States Court of Appeals Fifth Circuit No. 24-10600 ____________ FILED December 11, 2025 United States of America, Lyle W. Cayce Clerk Plaintiff—Appellee,

versus

Ray Anthony Shoulders,

Defendant—Appellant. ______________________________

Appeal from the United States District Court for the Northern District of Texas USDC No. 4:23-CR-207-1 ______________________________

Before Dennis, Graves, and Duncan, Circuit Judges. Per Curiam: *1 Ray Anthony Shoulders, a physician’s assistant, gave his patients amniotic fluid injections for pain management. He billed Medicare for these injections, but neither the procedure nor the product he used were approved for reimbursement. He was convicted of twelve counts of health care fraud

_____________________ * This opinion is not designated for publication. See 5th Cir. R. 47.5. 1 Judge Dennis concurs in the judgment. Although he believes it is at least debatable whether the district court erred in giving the deliberate-ignorance instruction, he agrees that any error was harmless. Case: 24-10600 Document: 91-1 Page: 2 Date Filed: 12/11/2025

No. 24-10600

and one count of conspiracy to commit health care fraud. On appeal, he challenges the district court’s decision to instruct the jury on deliberate ignorance and the sufficiency of the evidence on the conspiracy charge. We AFFIRM. I. Shoulders was a physician’s assistant (“PA”) at Southwest Sports and Spine (“SWSS”), a pain management clinic. He worked under Dr. Robert Menzies and was paid a 35% commission for his services, so his salary was based on amounts reimbursed by Medicare and insurance companies. Shoulders and Menzies, along with a nurse practitioner, Hayley Gulilat, began using amniotic fluid injections to treat orthopedic pain, but such products were not approved for either orthopedic conditions or pain management. They initially used “Cell Genuity,” with patients paying out- of-pocket. In August 2020, Shoulders learned from a marketer selling a different amniotic fluid injection product, “Fluid Flow,” that some providers had been able to bill Medicare for the product using the q-code “Q4206,” which was unique to Fluid Flow. Fluid Flow was significantly more expensive than Cell Genuity and Shoulders told Lori Payne, SWSS’ billing manager, to add Q4206 to SWSS’ billing system, saying that it was “like Christmas around here!” Using Dr. Menzies’ National Provider Identifier(“NPI”), both Shoulders and Gulilat began submitting claims to Medicare for using Fluid Flow when, in fact, they were still using Cell Genuity. Shoulders, as a PA, had his own NPI, but because Menzies was a physician, Medicare reimbursed claims under his NPI at a higher rate. Despite billing Medicare for his involvement, Menzies was never in the room when Shoulders administered the injections. After submitting two amniotic fluid injections to Medicare,

2 Case: 24-10600 Document: 91-1 Page: 3 Date Filed: 12/11/2025

Shoulders texted both Gulilat and Menzies that he was “sweating on reimbursements lol.” Later, he texted that he was up “thinking about medicare amnios,” and Gulilat and Menzies responded jovially. Shoulders also told a Cell Genuity sales representative that he was using the q-code to bill Medicare for amniotic fluid injections, saying “Bro, this is retirement early.” Amanda Petroff, an employee in the clinic’s billing office, discovered that the q-code should only be used for Fluid Flow injections, so she raised these concerns with the office manager, who deferred to Shoulders. She was also tasked with creating a hardship form for patients to apply to waive the copay on the procedures being billed to Medicare. Shoulders used the form to ensure that many patients did not pay anything for the injections. Denise Scott, a former Special Agent with the United States Department of Health and Human Services Office of the Inspector General, testified that often in healthcare fraud schemes, providers will see to it that patients are not responsible for the copay because, if the procedure is completely free, they are more likely to do it. Eventually, Payne emailed Shoulders that Medicare had reimbursed SWSS for one of the injections and Shoulders responded, “This is a proud MOMENT.” Payne asked Shoulders if she should contact Fluid Flow’s sales representative to purchase more, but Shoulders declined. He continued to inject patients using Cell Genuity and did not purchase any additional Fluid Flow. Menzies later texted Shoulders that he couldn’t “believe you got Medicare to pay for amnio.” Shoulders responded that he would “do as many as I can before Medicare decides not to pay for [it].” He rapidly increased the number of injections he billed Medicare for, performing a total of 125 injections in August, September, October of 2020. Employees were even asked to work overtime to accommodate the number of injections. At one point, Petroff confronted Shoulders about continuing to use the q-code,

3 Case: 24-10600 Document: 91-1 Page: 4 Date Filed: 12/11/2025

but Shoulders told her that he had been informed by the sales representative that it was covered and he would continue to use it. But Cell Genuity’s sales representative never told customers that Medicare would reimburse providers for it. At the end of October, the American Society of Interventional Pain Physicians (“ASIPP”) alerted clinics that, despite claims by some sales representatives to the contrary, Medicare did not reimburse for amniotic fluid products used for pain management. ASIPP also warned that providers should not bill Medicare or other insurers for using these products and that knowingly doing so could result in criminal penalties. Menzies emailed Gulilat and Shoulders the alert, telling them “We need to discuss as a team how to proceed.” Shoulders emailed ASIPP’s general email address asking for additional guidance, but did not receive a response. Shoulders also reached out to Petroff, who told him the injections were not covered by Medicare. They then stopped billing Medicare for Fluid Flow, though SWSS had already received approximately $355,000 in reimbursements. During this time, Shoulders’ own income dramatically increased, and he paid off a significant amount of his mortgage. Over the next several months, Shoulders investigated whether other clinics were still successfully billing Medicare for Fluid Flow using the q- code. A Fluid Flow sales representative contacted him about purchasing some of her product and he told her “Lol, ASIPP not giving you guys any love right now.” He confirmed with her that clinics were still successfully using the q-code and that Medicare had not audited them. He then confirmed with another sales representative that clinics using the q-code had not been audited and offered to talk to another marketer about his “business model” because he was “making a killing.” But, as reflected in an FDA consumer alert issued in June, amniotic fluids were not approved for pain management.

4 Case: 24-10600 Document: 91-1 Page: 5 Date Filed: 12/11/2025

In September 2021, Shoulders, Menzies, and Gulilat began billing Medicare using the q-code once again. Eventually, Shoulders even began calling Cell Genuity “Fluid Flow.” But there were several differences between the two. They were packaged differently, and Cell Genuity could be stored at room temperature whereas Fluid Flow had to be kept frozen. Despite his assertions to Medicare, he used Fluid Flow “less than five times.” In December 2021, Medicare discontinued the use of the q-code. SWSS had already received approximately $614,000 using that same code. Shoulders was indicted and charged with one count of conspiracy to commit health care fraud in violation of 18 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Williams
264 F.3d 561 (Fifth Circuit, 2001)
United States v. Holmes
406 F.3d 337 (Fifth Circuit, 2005)
United States v. Freeman
434 F.3d 369 (Fifth Circuit, 2005)
United States v. Miller
588 F.3d 897 (Fifth Circuit, 2009)
United States v. Santos
589 F.3d 759 (Fifth Circuit, 2009)
United States v. Jacqualine Crawley
381 F. App'x 462 (Fifth Circuit, 2010)
United States v. Rios
636 F.3d 168 (Fifth Circuit, 2011)
United States v. Uriel Lara-Velasquez
919 F.2d 946 (Fifth Circuit, 1990)
United States v. Jaime Moreno-Gonzalez
662 F.3d 369 (Fifth Circuit, 2011)
United States v. Delgado
668 F.3d 219 (Fifth Circuit, 2012)
United States v. Juan Arturo Mendoza-Medina
346 F.3d 121 (Fifth Circuit, 2003)
United States v. Howard Grant
683 F.3d 639 (Fifth Circuit, 2012)
United States v. Janice Demmitt
706 F.3d 665 (Fifth Circuit, 2013)
United States v. Song Chon
713 F.3d 812 (Fifth Circuit, 2013)
United States v. Lia St. Junius
739 F.3d 193 (Fifth Circuit, 2013)
United States v. Mark Kuhrt
788 F.3d 403 (Fifth Circuit, 2015)
United States v. Daniel Stanford
823 F.3d 814 (Fifth Circuit, 2016)
United States v. Clarence Buck
847 F.3d 267 (Fifth Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Shoulders, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-shoulders-ca5-2025.